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Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eizElectrographic seizures are frequent in critically-ill neonates
[1]. In one of the most common conditions in the neonatal
intensive care unit – hypoxic-ischemic encephalopathy –
seizures occur in approximately 30–60% of patients [2,3]. Most
electrographic seizures occur in high-risk populations such as
patients with hypoxic-ischemic encephalopathy, stroke, cardiac
surgery, extracorporeal membrane oxygenation, or meningitis,
but can also occur in other neurologic and systemic conditions.
Many neonatal seizures present with only subtle or no clinical
signs [2]. Only the recent widespread use of continuous
electroencephalogram (cEEG) monitoring has revealed the
burden of electrographic seizures in critically-ill patients. cEEG
monitoring is growing exponentially at an approximate pace of
30% per year in both adults and children. Further, this increase
in cEEG use is likely to continue: in a survey of 137 intensivists
and neurophysiologists from 97 ICUs in the USA showed that, in
an ideal situation with unlimited resources, respondents would
monitor 10–30% more patients (depending on the speciﬁc
indication for cEEG) and 18% of respondents would increase
cEEG duration [3]. Electrographic seizure detection in the
intensive care unit is a relatively new and developing ﬁeld in
constant evolution.
The rationale for detecting electrographic seizures rests on the
assumption that detection and treatment will ultimately lead to
improvement. It is currently unknown whether electrographic
seizures independently damage the brain or whether they are
mere biomarkers of a worse underlying brain injury that is not
going to improve with antiepileptic drug treatment. A growing
body of literature demonstrates that electrographic seizure
burden is independently associated with worse outcomes and
suggests that electrographic seizures independently contribute to
brain damage. If we assume that electrographic seizures are
damaging the brain and antiepileptic drugs stop seizures and
improve outcomes, then we would not like to miss electrographic
seizures. A recent cost-effectiveness study showed that cEEGDOI of original article: http://dx.doi.org/10.1016/j.seizure.2015.09.014
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goods electrographic seizure detection rates for a moderate price
[4]. The American Clinical Neurophysiology Society’s guidelines
on cEEG in neonates state that ‘‘conventional video-EEG
monitoring is the gold standard for neonatal seizure detection
and quantiﬁcation and should be used whenever available for
seizure detection and differential diagnosis of abnormal appear-
ing, paroxysmal clinical events’’ [5]. However, cEEG monitoriza-
tion is resource intensive and requires costly equipment, and
demanding schedules from technologists and EEG readers. Both
the cost-effectiveness analysis and the American Clinical Neuro-
physiology Society’s guideline are based on current monitoring
practices where cEEGs are placed on patients with a high clinical
suspicion of seizures.
If cEEG monitoring spreads to lower-risk neonates, costs may
skyrocket. Therefore, screening strategies that identify patients
at higher risk for seizures are needed. Amplitude-integrated EEG
(aEEG) uses a limited montage – typically 2–4 electrodes – and
compresses the EEG tracing in time to provide a global overview
of brain cerebral activity. aEEG is a cheaper and much less
resource-intense alternative to cEEG. With relatively simple
training, intensivists and nurses can recognize the most
frequent EEG patterns and detect seizures in real time. On the
other hand, as a ‘‘reduced’’ version of cEEG, aEEG only provides a
rough overview of brain activity and may miss seizures that
occur far from the electrodes. In this issue of Seizure,
Rakshasbhuvankar et al. provide a systematic review on the
diagnostic efﬁcacy of aEEG compared with the current gold
standard of cEEG.
This study shows that aEEG yields highly variable sensitivities
and speciﬁcities and therefore the authors conclude that aEEG
cannot be recommended as the mainstay for diagnosis and
management of neonatal seizures. This conclusion is perfectly
valid based on the current data, and several points may be worth
highlighting.
aEEG performance partially depends on the degree of expertise
and familiarity with aEEG reading: studies on neonatologists or
other aEEG reading-trained personnel yielded sensitivities and
speciﬁcities in the 80–100% range, but performance dropped
dramatically in other groups. Further, not all aEEG set-ups are
equal; different technical factors such as number and location ofserved.
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outputs may inﬂuence performance. Future studies may have to
take into account the aEEG set-up and the reader’s expertise as
potential confounders. It may also be helpful to test different aEEG
set-ups in the same reader both before and after a training
intervention.
aEEG may be even superior to cEEG in some aspects such as
simplicity and timeliness. Intensive care unit personnel typically
require an electrophysiologist interpreting cEEGs, but, if properly
trained, neonatal intensive care unit personnel can directly
interpret aEEG at the bedside. Not needing an intermediate EEG
reader to extract the information from the aEEG output empowers
the intensive care unit personnel to real-time identiﬁcation of
seizures and major changes in brain activity. In contrast, cEEG does
not usually provide a real monitorization because data are
interpreted only intermittently and rarely in real time. Seizures
may be missed due to the very limited montage. In that sense, aEEG
may be compared to heart auscultation – a method that can be
easily applied at the bedside in real time by any provider – while
cEEG may be compared to echocardiography – a specialized
method that can only be used intermittently as it requires an
additional doctor to interpret the results, and both evaluations are
valuable and complement each other.
The study by Rakshasbhuvankar et al. evaluates seizure
detection as it is an easily quantiﬁable outcome, but the value of
aEEG does not reside only in detecting seizures. aEEG provides
other less quantiﬁable outcomes. The evaluation of the EEG
background and its changes over time is also clinically helpful.
The aEEG output permits identiﬁcation of changes in global
trends in brain activity over time better than the detailed output
of cEEG.
In summary, the study by Rakshasbhuvankar et al. is a timely
summary of a relevant topic: the place of aEEG in electrographic
seizure detection in neonates. The presented data suggest that
aEEG is a very good screening tool that identiﬁes neonates who
need a cEEG: those with EEG backgrounds associated with a high
risk for seizures and those with seizures detected on aEEG. In
this context, it is important to remember that even the gold-
standard – cEEG for 24–48 h – is also just a screening tool as it
may miss seizures that occur prior to cEEG placement and after
cEEG discontinuation. While the gold standard remains cEEG, it
may not be feasible in every neonate around the world
immediately. In our current practice, we currently use both
techniques complementarily, with immediate set up of the aEEG
at the bedside, and replacement with cEEG by a skilled
technician, usually rather within minutes than hours and as
soon as practically feasible. Future cost-effectiveness and
outcome studies on the yield of cEEG and aEEG may help
delineate further which option is best for individual neonates
treated in different settings and presenting with different risk
factors for electrographic seizures.Conﬂict of interest
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